Back

Welcome & introduction: Potent P2Y12 receptor inhibition – What can we learn from clinical practice?

28 August 2016 (12:45 - 12:50)
Organised by:
Congress Presentation Part of: Potent P2Y12 receptor inhibition – What can we learn from clinical practice? Thrombosis and platelets ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Kurt Huber

Sigmund Freud University Vienna, Vienna (Austria)

3 More presentations in this session

Presentation thumbnail
How to apply guidelines to clinical practice.
Professor A. Schaefer (Hannover, DE)
Presentation thumbnail
Optimising P2Y12 inhibition in real world clinical practice: clinical outcomes of prasugrel and ticagrelor.
Professor J. Jukema (Leiden, NL)
Presentation thumbnail
Discussion – Summary and closing remarks: potent P2Y12 receptor inhibition – What can we learn from clinical practice?
Professor K. Huber (Vienna, AT)

Access the full session

Session thumbnail
Potent P2Y12 receptor inhibition – What can we learn from clinical practice?

The Event

Event poster

ESC Congress 2016

28 August 2016 12:45 CET
You may be interested in
thumbnail
Congress Presentation
P2Y12 inhibitor monotherapy in patients undergoing PCI.
26 August 2022
thumbnail
Congress Presentation
1 September 2019
thumbnail
Congress Presentation
Choice of P2Y12 inhibitor and clinical outcomes in the AUGUSTUS study: support for an individualised approach
30 August 2020
thumbnail
Congress Presentation
Introduction
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources